BRZU:ARCA-Direxion Daily Brazil Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 47.4

Change

-7.65 (-13.89)%

Market Cap

USD 0.04B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the MSCI Brazil 25/50 Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the MSCI Brazil 25/50 Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of the large- and mid-cap segments of the Brazil equity market, covering approximately 85% of the free float-adjusted market capitalization in Brazil. It is non-diversified.

Inception Date: 10/04/2013

Primary Benchmark: MSCI Brazil 25-50 NR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.04%

Management Expense Ratio: 1.15 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 8.29B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.07B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 5.57B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.37B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.08B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 2.48B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.91B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 0.82B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.66B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.59B

ETFs Containing BRZU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.47% 96% N/A 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.47% 96% N/A 96% N/A
Trailing 12 Months  
Capital Gain -42.70% 22% F 8% B-
Dividend Return 3.97% 95% A 64% D
Total Return -38.73% 25% F 9% A-
Trailing 5 Years  
Capital Gain 3.38% 16% F 30% F
Dividend Return 32.76% 85% B 70% C-
Total Return 36.14% 25% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 82.39% 94% A 97% N/A
Dividend Return 86.44% 94% A 97% N/A
Total Return 4.05% 97% N/A 74% C
Risk Return Profile  
Volatility (Standard Deviation) 572.61% 6% D- 2% F
Risk Adjusted Return 15.10% 29% F 32% F
Market Capitalization 0.04B 55% F 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.